Caxton Associates (New York)’s Prospect Capital PSEC Stock Holding History
Bought
Maintained
Sold
Other funds holding PSEC
XF
RJA
TI
Caxton Associates (New York)'s PSEC Position: Q3 2024 in Review
Caxton Associates (New York) sold out of Prospect Capital (PSEC) in Q3 2024, closing a stake of 124,102 shares — an estimated $686K sold.
Caxton Associates (New York) first reported a position in PSEC in Q1 2017 and held it in 11 quarters. The position peaked at $1.43M in Q3 2023. 226 funds tracked by Wall St. Rank hold PSEC as of Q3 2024.
- Caxton Associates (New York) reported no remaining Prospect Capital position as of Q3 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 124,102 Prospect Capital shares in Q3 2024, an estimated $686K.
- Caxton Associates (New York) first reported a position in Prospect Capital in Q1 2017 and held it in 11 quarters.
- Caxton Associates (New York)'s Prospect Capital position peaked at $1.43M in Q3 2023.
- 226 funds tracked by Wall St. Rank held Prospect Capital as of Q3 2024.
Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.